You might want to look at another company in the device space. ECOR is already labeled for migraine and has done clinical trials. Doctors prefer meds and another medication is on the clinical path to FDA approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.